ASA physical status 1 or 2
Written informed consent
Cardiovascular disease
Pulmonary disease
Liver disease
CNS disease
Alcohol or drug abuse
Chronic intake of CNS active drugs
Body mass index > 35
Diabetes mellitus
Hypersensitivity or allergy to one of the study drugs

NCT02457442_inc_T1
Measurement
ASA physical status
NCT02457442_inc_T2
Value
1
NCT02457442_inc_T3
Value
2
NCT02457442_inc_T4
Scope
1 or 2
NCT02457442_inc_T6
Condition
Cardiovascular disease
NCT02457442_inc_T7
Condition
Pulmonary disease
NCT02457442_inc_T8
Condition
Liver disease
NCT02457442_inc_T9
Condition
CNS disease
NCT02457442_inc_T10
Condition
l or dr Chron
NCT02457442_inc_T11
Condition
drug abuse
NCT02457442_inc_T12
Multiplier
Chronic intake
NCT02457442_inc_T13
Drug
CNS active drugs
NCT02457442_inc_T14
Measurement
Body mass index
NCT02457442_inc_T15
Value
> 35
NCT02457442_inc_T16
Condition
Diabetes mellitus
NCT02457442_inc_T17
Condition
Hypersensitivity
NCT02457442_inc_T18
Condition
allergy
NCT02457442_inc_T19
Drug
study drugs
NCT02457442_inc_T20
Scope
Hypersensitivity or allergy